Skip to content
10-Q/A

Quarterly Report

Q BIOMED INC.

0001410578-23-001458

← back to feed
Filed
Jun 23, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jun 15, 2023 145.09M sh
Shares Diluted Q1 2023 · Feb 28, 2023 108.73M sh
Shares Diluted Q1 2023 · Feb 28, 2022 29.59M sh
Operating Cash Flow Q1 2023 · Feb 28, 2023 −$138.19K
Operating Cash Flow Q1 2023 · Feb 28, 2022 −$376.86K
Short Term Debt Q1 2023 · Feb 28, 2023 $4.08M
Short Term Debt Q1 2023 · Nov 30, 2022 $4.11M
Stockholders Equity Q1 2023 · Feb 28, 2023 −$6.44M
Stockholders Equity Q1 2023 · Nov 30, 2022 −$4.62M
Stockholders Equity Q1 2023 · Feb 28, 2022 −$5.83M
Stockholders Equity Q1 2023 · Nov 30, 2021 −$4.69M
Current Liabilities Q1 2023 · Feb 28, 2023 $9.91M
Current Liabilities Q1 2023 · Nov 30, 2022 $8.13M
Total Liabilities Q1 2023 · Feb 28, 2023 $9.91M
Total Liabilities Q1 2023 · Nov 30, 2022 $8.13M
Current Assets Q1 2023 · Feb 28, 2023 $33.98K
Current Assets Q1 2023 · Nov 30, 2022 $72.32K
Total Assets Q1 2023 · Feb 28, 2023 $3.46M
Total Assets Q1 2023 · Nov 30, 2022 $3.52M
Eps Diluted Q1 2023 · Feb 28, 2023 −$0.02
Eps Diluted Q1 2023 · Feb 28, 2022 −$0.08
Eps Basic Q1 2023 · Feb 28, 2023 −$0.02
Eps Basic Q1 2023 · Feb 28, 2022 −$0.08
Rd Expense Q1 2023 · Feb 28, 2023 $2.69K
Rd Expense Q1 2023 · Feb 28, 2022 $69.27K
Net Income Q1 2023 · Feb 28, 2023 −$721.61K
Net Income Q1 2023 · Feb 28, 2022 −$2.29M
Operating Income Q1 2023 · Feb 28, 2023 −$445.01K
Operating Income Q1 2023 · Feb 28, 2022 −$1.16M
Gross Profit Q1 2023 · Feb 28, 2023 −$2.5K
Gross Profit Q1 2023 · Feb 28, 2022 $1.11K
Cost Of Revenue Q1 2023 · Feb 28, 2023 $2.5K
Cost Of Revenue Q1 2023 · Feb 28, 2022 $73.95K
Revenue Q1 2023 · Feb 28, 2022 $75.06K